Learning from COVID-19 related trial adaptations to inform efficient trial design—a sequential mixed methods study View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-04-29

AUTHORS

Robin Chatters, Cindy L. Cooper, Alicia O’Cathain, Caroline Murphy, Athene Lane, Katie Sutherland, Christopher Burton, Angela Cape, Louis Tunnicliffe

ABSTRACT

BackgroundMany clinical trial procedures were often undertaken in-person prior to the COVID-19 pandemic, which has resulted in adaptations to these procedures to enable trials to continue. The aim of this study was to understand whether the adaptations made to clinical trials by UK Clinical Trials Units (CTUs) during the pandemic have the potential to improve the efficiency of trials post-pandemic.MethodsThis was a mixed methods study, initially involving an online survey administered to all registered UK CTUs to identify studies that had made adaptations due to the pandemic. Representatives from selected studies were qualitatively interviewed to explore the adaptations made and their potential to improve the efficiency of future trials. A literature review was undertaken to locate published evidence concerning the investigated adaptations. The findings from the interviews were reviewed by a group of CTU and patient representatives within a workshop, where discussions focused on the potential of the adaptations to improve the efficiency of future trials.ResultsForty studies were identified by the survey. Fourteen studies were selected and fifteen CTU staff were interviewed about the adaptations. The workshop included 15 CTU and 3 patient representatives. Adaptations were not seen as leading to direct efficiency savings for CTUs. However, three adaptations may have the potential to directly improve efficiencies for trial sites and participants beyond the pandemic: a split remote-first eligibility assessment, recruitment outside the NHS via a charity, and remote consent. There was a lack of published evidence to support the former two adaptations, however, remote consent is widely supported in the literature. Other identified adaptations may benefit by improving flexibility for the participant. Barriers to using these adaptations include the impact on scientific validity, limitations in the role of the CTU, and participant’s access to technology.ConclusionsThree adaptations (a split remote-first eligibility assessment, recruitment outside the NHS via a charity, and remote consent) have the potential to improve clinical trials but only one (remote consent) is supported by evidence. These adaptations could be tested in future co-ordinated ‘studies within a trial’ (SWAT). More... »

PAGES

128

References to SciGraph publications

  • 2018-01-08. Trial management– building the evidence base for decision-making in TRIALS
  • 2020-09-11. It is unprecedented: trial management during the COVID-19 pandemic and beyond in TRIALS
  • 2013-06-22. Feasibility and Acceptability of Alternate Methods of Postnatal Data Collection in MATERNAL AND CHILD HEALTH JOURNAL
  • 2018-10-24. Feasibility of weekly participant-reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema) in TRIALS
  • 2009-12-30. Effects of phone versus mail survey methods on the measurement of health-related quality of life and emotional and behavioural problems in adolescents in BMC PUBLIC HEALTH
  • 2021-02-19. Patient perceptions, opinions and satisfaction of telehealth with remote blood pressure monitoring postpartum in BMC PREGNANCY AND CHILDBIRTH
  • 2021-01-18. Managing clinical trials during COVID-19: experience from a clinical research facility in TRIALS
  • 2021-01-03. Trends in and determinants of visiting private health facilities for maternal and child health care in Nepal: comparison of three Nepal demographic health surveys, 2006, 2011, and 2016 in BMC PREGNANCY AND CHILDBIRTH
  • 2021-02-27. Digital tools in the informed consent process: a systematic review in BMC MEDICAL ETHICS
  • 2018-01-03. Minimally invasive versus open pancreatoduodenectomy (LEOPARD-2): study protocol for a randomized controlled trial in TRIALS
  • 2014-04-09. Inter-method reliability of paper surveys and computer assisted telephone interviews in a randomized controlled trial of yoga for low back pain in BMC RESEARCH NOTES
  • 2018-02-23. Trial Forge Guidance 1: what is a Study Within A Trial (SWAT)? in TRIALS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/s12874-022-01609-6

    DOI

    http://dx.doi.org/10.1186/s12874-022-01609-6

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1147499753

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/35488193


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Public Health and Health Services", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "COVID-19", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Clinical Trials as Topic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pandemics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Research Design", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Surveys and Questionnaires", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Sheffield Clinical Trials Research Unit, School of Health and Related Research, The University of Sheffield, Regents Court, Regent Street, S1 4DA, Sheffield, England", 
              "id": "http://www.grid.ac/institutes/grid.11835.3e", 
              "name": [
                "Sheffield Clinical Trials Research Unit, School of Health and Related Research, The University of Sheffield, Regents Court, Regent Street, S1 4DA, Sheffield, England"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chatters", 
            "givenName": "Robin", 
            "id": "sg:person.01010766776.96", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010766776.96"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Sheffield Clinical Trials Research Unit, School of Health and Related Research, The University of Sheffield, Regents Court, Regent Street, S1 4DA, Sheffield, England", 
              "id": "http://www.grid.ac/institutes/grid.11835.3e", 
              "name": [
                "Sheffield Clinical Trials Research Unit, School of Health and Related Research, The University of Sheffield, Regents Court, Regent Street, S1 4DA, Sheffield, England"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cooper", 
            "givenName": "Cindy L.", 
            "id": "sg:person.0757620634.52", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757620634.52"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Medical Care Research Unit, School of Health and Related Research, The University of Sheffield, Sheffield, UK", 
              "id": "http://www.grid.ac/institutes/grid.11835.3e", 
              "name": [
                "Medical Care Research Unit, School of Health and Related Research, The University of Sheffield, Sheffield, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "O\u2019Cathain", 
            "givenName": "Alicia", 
            "id": "sg:person.01336775314.64", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336775314.64"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "King\u2019s Clinical Trials Unit, King\u2019s College London, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.13097.3c", 
              "name": [
                "King\u2019s Clinical Trials Unit, King\u2019s College London, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Murphy", 
            "givenName": "Caroline", 
            "id": "sg:person.0716374270.06", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716374270.06"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Bristol Randomised Trials Collaboration in the Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, England", 
              "id": "http://www.grid.ac/institutes/grid.5337.2", 
              "name": [
                "Bristol Randomised Trials Collaboration in the Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, England"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lane", 
            "givenName": "Athene", 
            "id": "sg:person.0641266266.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641266266.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Sheffield Clinical Trials Research Unit, School of Health and Related Research, The University of Sheffield, Regents Court, Regent Street, S1 4DA, Sheffield, England", 
              "id": "http://www.grid.ac/institutes/grid.11835.3e", 
              "name": [
                "Sheffield Clinical Trials Research Unit, School of Health and Related Research, The University of Sheffield, Regents Court, Regent Street, S1 4DA, Sheffield, England"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sutherland", 
            "givenName": "Katie", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Academic Unit of Primary Medical Care, The University of Sheffield, Sheffield, UK", 
              "id": "http://www.grid.ac/institutes/grid.11835.3e", 
              "name": [
                "Academic Unit of Primary Medical Care, The University of Sheffield, Sheffield, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Burton", 
            "givenName": "Christopher", 
            "id": "sg:person.01174540677.71", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174540677.71"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "King\u2019s Clinical Trials Unit, King\u2019s College London, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.13097.3c", 
              "name": [
                "King\u2019s Clinical Trials Unit, King\u2019s College London, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cape", 
            "givenName": "Angela", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "London School of Hygiene & Tropical Medicine, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.8991.9", 
              "name": [
                "London School of Hygiene & Tropical Medicine, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tunnicliffe", 
            "givenName": "Louis", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s10995-013-1310-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013176054", 
              "https://doi.org/10.1007/s10995-013-1310-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1471-2458-9-491", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053185544", 
              "https://doi.org/10.1186/1471-2458-9-491"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1756-0500-7-227", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042202269", 
              "https://doi.org/10.1186/1756-0500-7-227"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13063-020-05004-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1134680043", 
              "https://doi.org/10.1186/s13063-020-05004-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13063-018-2962-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1107825609", 
              "https://doi.org/10.1186/s13063-018-2962-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13063-017-2423-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1100166571", 
              "https://doi.org/10.1186/s13063-017-2423-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12884-020-03485-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1134286028", 
              "https://doi.org/10.1186/s12884-020-03485-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13063-017-2322-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1100258793", 
              "https://doi.org/10.1186/s13063-017-2322-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12884-021-03632-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1135467397", 
              "https://doi.org/10.1186/s12884-021-03632-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13063-020-04711-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1130786911", 
              "https://doi.org/10.1186/s13063-020-04711-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12910-021-00585-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1135806869", 
              "https://doi.org/10.1186/s12910-021-00585-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13063-018-2535-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1101180956", 
              "https://doi.org/10.1186/s13063-018-2535-5"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2022-04-29", 
        "datePublishedReg": "2022-04-29", 
        "description": "BackgroundMany clinical trial procedures were often undertaken in-person prior to the COVID-19 pandemic, which has resulted in adaptations to these procedures to enable trials to continue. The aim of this study was to understand whether the adaptations made to clinical trials by UK Clinical Trials Units (CTUs) during the pandemic have the potential to improve the efficiency of trials post-pandemic.MethodsThis was a mixed methods study, initially involving an online survey administered to all registered UK CTUs to identify studies that had made adaptations due to the pandemic. Representatives from selected studies were qualitatively interviewed to explore the adaptations made and their potential to improve the efficiency of future trials. A literature review was undertaken to locate published evidence concerning the investigated adaptations. The findings from the interviews were reviewed by a group of CTU and patient representatives within a workshop, where discussions focused on the potential of the adaptations to improve the efficiency of future trials.ResultsForty studies were identified by the survey. Fourteen studies were selected and fifteen CTU staff were interviewed about the adaptations. The workshop included 15 CTU and 3 patient representatives. Adaptations were not seen as leading to direct efficiency savings for CTUs. However, three adaptations may have the potential to directly improve efficiencies for trial sites and participants beyond the pandemic: a split remote-first eligibility assessment, recruitment outside the NHS via a charity, and remote consent. There was a lack of published evidence to support the former two adaptations, however, remote consent is widely supported in the literature. Other identified adaptations may benefit by improving flexibility for the participant. Barriers to using these adaptations include the impact on scientific validity, limitations in the role of the CTU, and participant\u2019s access to technology.ConclusionsThree adaptations (a split remote-first eligibility assessment, recruitment outside the NHS via a charity, and remote consent) have the potential to improve clinical trials but only one (remote consent) is supported by evidence. These adaptations could be tested in future co-ordinated \u2018studies within a trial\u2019 (SWAT).", 
        "genre": "article", 
        "id": "sg:pub.10.1186/s12874-022-01609-6", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1024940", 
            "issn": [
              "1471-2288"
            ], 
            "name": "BMC Medical Research Methodology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "22"
          }
        ], 
        "keywords": [
          "Clinical Trials Unit", 
          "UK Clinical Trials Units", 
          "future trials", 
          "clinical trials", 
          "patient representatives", 
          "remote consent", 
          "efficient trial design", 
          "clinical trial procedures", 
          "ResultsForty studies", 
          "trial design", 
          "methods study", 
          "eligibility assessment", 
          "Trials Unit", 
          "trials", 
          "efficiency of trials", 
          "mixed-methods study", 
          "COVID-19", 
          "COVID-19 pandemic", 
          "trial procedures", 
          "trial adaptation", 
          "pandemic", 
          "consent", 
          "participants' access", 
          "literature review", 
          "trial sites", 
          "participants", 
          "online survey", 
          "MethodsThis", 
          "evidence", 
          "study", 
          "scientific validity", 
          "NHS", 
          "procedure", 
          "survey", 
          "review", 
          "group", 
          "aim", 
          "staff", 
          "findings", 
          "persons", 
          "recruitment", 
          "assessment", 
          "potential", 
          "adaptation", 
          "access", 
          "role", 
          "interviews", 
          "lack", 
          "barriers", 
          "workshop", 
          "literature", 
          "sites", 
          "units", 
          "impact", 
          "validity", 
          "efficiency savings", 
          "limitations", 
          "representatives", 
          "discussion", 
          "design", 
          "savings", 
          "charity", 
          "efficiency", 
          "technology", 
          "flexibility"
        ], 
        "name": "Learning from COVID-19 related trial adaptations to inform efficient trial design\u2014a sequential mixed methods study", 
        "pagination": "128", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1147499753"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/s12874-022-01609-6"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "35488193"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/s12874-022-01609-6", 
          "https://app.dimensions.ai/details/publication/pub.1147499753"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-06-01T22:24", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_939.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/s12874-022-01609-6"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12874-022-01609-6'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12874-022-01609-6'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12874-022-01609-6'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12874-022-01609-6'


     

    This table displays all metadata directly associated to this object as RDF triples.

    264 TRIPLES      22 PREDICATES      109 URIs      89 LITERALS      13 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/s12874-022-01609-6 schema:about N1ee8800717e24e9aab770e5387908114
    2 N2212cd16d6d04e3399f1514d529acad8
    3 N4387a31c18624fa1ad9146c3f4a5d36d
    4 N931def46b14f42b58fdfa31afaee9014
    5 Nc3309c23527d4945849de0aa0f985a48
    6 Nd669bb0bf5754c1dbe116df5cd5f8e72
    7 anzsrc-for:11
    8 anzsrc-for:1117
    9 schema:author N1e7bcff3bbec4a79ac2e033052913b3d
    10 schema:citation sg:pub.10.1007/s10995-013-1310-1
    11 sg:pub.10.1186/1471-2458-9-491
    12 sg:pub.10.1186/1756-0500-7-227
    13 sg:pub.10.1186/s12884-020-03485-8
    14 sg:pub.10.1186/s12884-021-03632-9
    15 sg:pub.10.1186/s12910-021-00585-8
    16 sg:pub.10.1186/s13063-017-2322-8
    17 sg:pub.10.1186/s13063-017-2423-4
    18 sg:pub.10.1186/s13063-018-2535-5
    19 sg:pub.10.1186/s13063-018-2962-3
    20 sg:pub.10.1186/s13063-020-04711-6
    21 sg:pub.10.1186/s13063-020-05004-8
    22 schema:datePublished 2022-04-29
    23 schema:datePublishedReg 2022-04-29
    24 schema:description BackgroundMany clinical trial procedures were often undertaken in-person prior to the COVID-19 pandemic, which has resulted in adaptations to these procedures to enable trials to continue. The aim of this study was to understand whether the adaptations made to clinical trials by UK Clinical Trials Units (CTUs) during the pandemic have the potential to improve the efficiency of trials post-pandemic.MethodsThis was a mixed methods study, initially involving an online survey administered to all registered UK CTUs to identify studies that had made adaptations due to the pandemic. Representatives from selected studies were qualitatively interviewed to explore the adaptations made and their potential to improve the efficiency of future trials. A literature review was undertaken to locate published evidence concerning the investigated adaptations. The findings from the interviews were reviewed by a group of CTU and patient representatives within a workshop, where discussions focused on the potential of the adaptations to improve the efficiency of future trials.ResultsForty studies were identified by the survey. Fourteen studies were selected and fifteen CTU staff were interviewed about the adaptations. The workshop included 15 CTU and 3 patient representatives. Adaptations were not seen as leading to direct efficiency savings for CTUs. However, three adaptations may have the potential to directly improve efficiencies for trial sites and participants beyond the pandemic: a split remote-first eligibility assessment, recruitment outside the NHS via a charity, and remote consent. There was a lack of published evidence to support the former two adaptations, however, remote consent is widely supported in the literature. Other identified adaptations may benefit by improving flexibility for the participant. Barriers to using these adaptations include the impact on scientific validity, limitations in the role of the CTU, and participant’s access to technology.ConclusionsThree adaptations (a split remote-first eligibility assessment, recruitment outside the NHS via a charity, and remote consent) have the potential to improve clinical trials but only one (remote consent) is supported by evidence. These adaptations could be tested in future co-ordinated ‘studies within a trial’ (SWAT).
    25 schema:genre article
    26 schema:inLanguage en
    27 schema:isAccessibleForFree true
    28 schema:isPartOf Na14ebda7bf434bf89c89d6df1f65c775
    29 Nec7839aab3a94ec1b1ccad0051e4d5d1
    30 sg:journal.1024940
    31 schema:keywords COVID-19
    32 COVID-19 pandemic
    33 Clinical Trials Unit
    34 MethodsThis
    35 NHS
    36 ResultsForty studies
    37 Trials Unit
    38 UK Clinical Trials Units
    39 access
    40 adaptation
    41 aim
    42 assessment
    43 barriers
    44 charity
    45 clinical trial procedures
    46 clinical trials
    47 consent
    48 design
    49 discussion
    50 efficiency
    51 efficiency of trials
    52 efficiency savings
    53 efficient trial design
    54 eligibility assessment
    55 evidence
    56 findings
    57 flexibility
    58 future trials
    59 group
    60 impact
    61 interviews
    62 lack
    63 limitations
    64 literature
    65 literature review
    66 methods study
    67 mixed-methods study
    68 online survey
    69 pandemic
    70 participants
    71 participants' access
    72 patient representatives
    73 persons
    74 potential
    75 procedure
    76 recruitment
    77 remote consent
    78 representatives
    79 review
    80 role
    81 savings
    82 scientific validity
    83 sites
    84 staff
    85 study
    86 survey
    87 technology
    88 trial adaptation
    89 trial design
    90 trial procedures
    91 trial sites
    92 trials
    93 units
    94 validity
    95 workshop
    96 schema:name Learning from COVID-19 related trial adaptations to inform efficient trial design—a sequential mixed methods study
    97 schema:pagination 128
    98 schema:productId Nb2b5791aef7746afa58cade020def0f3
    99 Ne55a0d2f432343dcbb2eef9bcd49081e
    100 Neafe92e5c70842a4bd29b41a67249226
    101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1147499753
    102 https://doi.org/10.1186/s12874-022-01609-6
    103 schema:sdDatePublished 2022-06-01T22:24
    104 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    105 schema:sdPublisher Nf9e68ab7c5be48138f7c517b037c8e9c
    106 schema:url https://doi.org/10.1186/s12874-022-01609-6
    107 sgo:license sg:explorer/license/
    108 sgo:sdDataset articles
    109 rdf:type schema:ScholarlyArticle
    110 N10c7e1121d794ccd8c6130bb445b3c91 schema:affiliation grid-institutes:grid.11835.3e
    111 schema:familyName Sutherland
    112 schema:givenName Katie
    113 rdf:type schema:Person
    114 N1e7bcff3bbec4a79ac2e033052913b3d rdf:first sg:person.01010766776.96
    115 rdf:rest Nab3da188fd054796a395f4efaae65df8
    116 N1ee8800717e24e9aab770e5387908114 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    117 schema:name Surveys and Questionnaires
    118 rdf:type schema:DefinedTerm
    119 N2212cd16d6d04e3399f1514d529acad8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    120 schema:name Pandemics
    121 rdf:type schema:DefinedTerm
    122 N29ea841774964a8799abb090362bfadd rdf:first sg:person.0641266266.22
    123 rdf:rest N8d061b52b9ac4884bc7ebe8aa11dd739
    124 N4387a31c18624fa1ad9146c3f4a5d36d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    125 schema:name COVID-19
    126 rdf:type schema:DefinedTerm
    127 N58feb4e5002840ada88c83c4d85f4ed4 rdf:first N917b8bb1aaec41d48bcb0e5c5dab110c
    128 rdf:rest rdf:nil
    129 N5d2ee6d15b124f2ab83ac8be1d1d4c50 rdf:first sg:person.01174540677.71
    130 rdf:rest Na46c9cb3eaca478b902481121a726b3e
    131 N8d061b52b9ac4884bc7ebe8aa11dd739 rdf:first N10c7e1121d794ccd8c6130bb445b3c91
    132 rdf:rest N5d2ee6d15b124f2ab83ac8be1d1d4c50
    133 N917b8bb1aaec41d48bcb0e5c5dab110c schema:affiliation grid-institutes:grid.8991.9
    134 schema:familyName Tunnicliffe
    135 schema:givenName Louis
    136 rdf:type schema:Person
    137 N931def46b14f42b58fdfa31afaee9014 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Clinical Trials as Topic
    139 rdf:type schema:DefinedTerm
    140 N9f5965674437461ca4e5bc8ab546f9a6 schema:affiliation grid-institutes:grid.13097.3c
    141 schema:familyName Cape
    142 schema:givenName Angela
    143 rdf:type schema:Person
    144 Na14ebda7bf434bf89c89d6df1f65c775 schema:issueNumber 1
    145 rdf:type schema:PublicationIssue
    146 Na46c9cb3eaca478b902481121a726b3e rdf:first N9f5965674437461ca4e5bc8ab546f9a6
    147 rdf:rest N58feb4e5002840ada88c83c4d85f4ed4
    148 Nab3da188fd054796a395f4efaae65df8 rdf:first sg:person.0757620634.52
    149 rdf:rest Nb4ae4273c4fc4da9aca50c45ad587b8d
    150 Nb2b5791aef7746afa58cade020def0f3 schema:name doi
    151 schema:value 10.1186/s12874-022-01609-6
    152 rdf:type schema:PropertyValue
    153 Nb4ae4273c4fc4da9aca50c45ad587b8d rdf:first sg:person.01336775314.64
    154 rdf:rest Nd24dc6307fae4ee690fd167226e1bc02
    155 Nc3309c23527d4945849de0aa0f985a48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    156 schema:name Research Design
    157 rdf:type schema:DefinedTerm
    158 Nd24dc6307fae4ee690fd167226e1bc02 rdf:first sg:person.0716374270.06
    159 rdf:rest N29ea841774964a8799abb090362bfadd
    160 Nd669bb0bf5754c1dbe116df5cd5f8e72 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    161 schema:name Humans
    162 rdf:type schema:DefinedTerm
    163 Ne55a0d2f432343dcbb2eef9bcd49081e schema:name pubmed_id
    164 schema:value 35488193
    165 rdf:type schema:PropertyValue
    166 Neafe92e5c70842a4bd29b41a67249226 schema:name dimensions_id
    167 schema:value pub.1147499753
    168 rdf:type schema:PropertyValue
    169 Nec7839aab3a94ec1b1ccad0051e4d5d1 schema:volumeNumber 22
    170 rdf:type schema:PublicationVolume
    171 Nf9e68ab7c5be48138f7c517b037c8e9c schema:name Springer Nature - SN SciGraph project
    172 rdf:type schema:Organization
    173 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    174 schema:name Medical and Health Sciences
    175 rdf:type schema:DefinedTerm
    176 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
    177 schema:name Public Health and Health Services
    178 rdf:type schema:DefinedTerm
    179 sg:journal.1024940 schema:issn 1471-2288
    180 schema:name BMC Medical Research Methodology
    181 schema:publisher Springer Nature
    182 rdf:type schema:Periodical
    183 sg:person.01010766776.96 schema:affiliation grid-institutes:grid.11835.3e
    184 schema:familyName Chatters
    185 schema:givenName Robin
    186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010766776.96
    187 rdf:type schema:Person
    188 sg:person.01174540677.71 schema:affiliation grid-institutes:grid.11835.3e
    189 schema:familyName Burton
    190 schema:givenName Christopher
    191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174540677.71
    192 rdf:type schema:Person
    193 sg:person.01336775314.64 schema:affiliation grid-institutes:grid.11835.3e
    194 schema:familyName O’Cathain
    195 schema:givenName Alicia
    196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336775314.64
    197 rdf:type schema:Person
    198 sg:person.0641266266.22 schema:affiliation grid-institutes:grid.5337.2
    199 schema:familyName Lane
    200 schema:givenName Athene
    201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641266266.22
    202 rdf:type schema:Person
    203 sg:person.0716374270.06 schema:affiliation grid-institutes:grid.13097.3c
    204 schema:familyName Murphy
    205 schema:givenName Caroline
    206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716374270.06
    207 rdf:type schema:Person
    208 sg:person.0757620634.52 schema:affiliation grid-institutes:grid.11835.3e
    209 schema:familyName Cooper
    210 schema:givenName Cindy L.
    211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757620634.52
    212 rdf:type schema:Person
    213 sg:pub.10.1007/s10995-013-1310-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013176054
    214 https://doi.org/10.1007/s10995-013-1310-1
    215 rdf:type schema:CreativeWork
    216 sg:pub.10.1186/1471-2458-9-491 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053185544
    217 https://doi.org/10.1186/1471-2458-9-491
    218 rdf:type schema:CreativeWork
    219 sg:pub.10.1186/1756-0500-7-227 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042202269
    220 https://doi.org/10.1186/1756-0500-7-227
    221 rdf:type schema:CreativeWork
    222 sg:pub.10.1186/s12884-020-03485-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1134286028
    223 https://doi.org/10.1186/s12884-020-03485-8
    224 rdf:type schema:CreativeWork
    225 sg:pub.10.1186/s12884-021-03632-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1135467397
    226 https://doi.org/10.1186/s12884-021-03632-9
    227 rdf:type schema:CreativeWork
    228 sg:pub.10.1186/s12910-021-00585-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1135806869
    229 https://doi.org/10.1186/s12910-021-00585-8
    230 rdf:type schema:CreativeWork
    231 sg:pub.10.1186/s13063-017-2322-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100258793
    232 https://doi.org/10.1186/s13063-017-2322-8
    233 rdf:type schema:CreativeWork
    234 sg:pub.10.1186/s13063-017-2423-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100166571
    235 https://doi.org/10.1186/s13063-017-2423-4
    236 rdf:type schema:CreativeWork
    237 sg:pub.10.1186/s13063-018-2535-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101180956
    238 https://doi.org/10.1186/s13063-018-2535-5
    239 rdf:type schema:CreativeWork
    240 sg:pub.10.1186/s13063-018-2962-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107825609
    241 https://doi.org/10.1186/s13063-018-2962-3
    242 rdf:type schema:CreativeWork
    243 sg:pub.10.1186/s13063-020-04711-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1130786911
    244 https://doi.org/10.1186/s13063-020-04711-6
    245 rdf:type schema:CreativeWork
    246 sg:pub.10.1186/s13063-020-05004-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1134680043
    247 https://doi.org/10.1186/s13063-020-05004-8
    248 rdf:type schema:CreativeWork
    249 grid-institutes:grid.11835.3e schema:alternateName Academic Unit of Primary Medical Care, The University of Sheffield, Sheffield, UK
    250 Medical Care Research Unit, School of Health and Related Research, The University of Sheffield, Sheffield, UK
    251 Sheffield Clinical Trials Research Unit, School of Health and Related Research, The University of Sheffield, Regents Court, Regent Street, S1 4DA, Sheffield, England
    252 schema:name Academic Unit of Primary Medical Care, The University of Sheffield, Sheffield, UK
    253 Medical Care Research Unit, School of Health and Related Research, The University of Sheffield, Sheffield, UK
    254 Sheffield Clinical Trials Research Unit, School of Health and Related Research, The University of Sheffield, Regents Court, Regent Street, S1 4DA, Sheffield, England
    255 rdf:type schema:Organization
    256 grid-institutes:grid.13097.3c schema:alternateName King’s Clinical Trials Unit, King’s College London, London, UK
    257 schema:name King’s Clinical Trials Unit, King’s College London, London, UK
    258 rdf:type schema:Organization
    259 grid-institutes:grid.5337.2 schema:alternateName Bristol Randomised Trials Collaboration in the Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, England
    260 schema:name Bristol Randomised Trials Collaboration in the Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, England
    261 rdf:type schema:Organization
    262 grid-institutes:grid.8991.9 schema:alternateName London School of Hygiene & Tropical Medicine, London, UK
    263 schema:name London School of Hygiene & Tropical Medicine, London, UK
    264 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...